New flu drug shows promise in kids – phase 2 trial complete
NCT ID NCT06656026
First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tested a new flu medicine called ZSP1273 in 72 children aged 2 to 17 who had influenza A. The goal was to check how safe the drug is, how it moves through the body, and how well it works. Researchers measured drug levels in the blood, tracked side effects, and recorded how long flu symptoms lasted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.